• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	RetinalGenix Technologies Inc. (RTGN)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date			2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023
Total Revenue
QoQ%
YoY%
Cost Of Revenue
Gross Profit
Gross Margin
Operating Expenses			622,059$	567,833$	648,348$	586,350$	866,067$	643,331$	662,673$	2,144,916$	540,676$	685,507$	351,183$	509,683$
Operating Income
Operating Margin
Interest Income
Interest Expenses										960$				960$
Income Before Tax			(623,127$)	(568,791$)	(649,418$)	(587,259$)	(867,027$)	(644,291$)	(663,633$)	(2,145,876$)	(541,636$)	(686,467$)	(352,143$)	(510,643$)
Tax Expenses
Net Income			(623,127$)	(568,791$)	(649,418$)	(587,259$)	(867,027$)	(644,291$)	(663,633$)	(2,145,876$)	(541,636$)	(686,467$)	(352,143$)	(510,643$)
Profit Margin
TTM
Earnings to Minority
Earnings to Common Shareholders			(623,127$)	(568,791$)	(649,418$)	(587,259$)	(867,027$)	(644,291$)	(663,633$)	(2,145,876$)	(541,636$)	(686,467$)	(352,143$)	(510,643$)
QoQ%			(9.55%)	12.42%	(10.59%)	32.27%	(34.57%)	2.92%	69.07%	(296.18%)	21.10%	(94.94%)	31.04%
YoY%			28.13%	11.72%	2.14%	72.63%	(60.08%)	6.14%	(88.46%)	(320.23%)
Earnings Per Share, Basic			(0.03$)	(0.03$)	(0.04$)	(0.03$)	(0.05$)	(0.04$)	(0.04$)	(0.12$)	(0.03$)	(0.04$)	(0.02$)	(0.03$)
Earnings Per Share, Diluted			(0.03$)	(0.03$)	(0.04$)	(0.03$)	(0.05$)	(0.04$)	(0.04$)	(0.12$)	(0.03$)	(0.04$)	(0.02$)	(0.03$)
Unlevered FCF Per Share, Basic			(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.02$)	0.00$	(0.01$)	0.00$
Unlevered FCF Per Share, Diluted			(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.01$)	(0.02$)	0.00$	(0.01$)	0.00$
Average Shares, Basic			18,821,710	18,579,776	18,326,587	18,522,295	18,256,727	17,970,120	17,863,564	17,672,145	17,588,917	17,275,635	17,272,116	17,272,116
Average Shares, Diluted			18,821,710	18,579,776	18,326,587	18,522,295	18,256,727	17,970,120	17,863,564	17,672,145	17,588,917	17,275,635	17,272,116	17,272,116
EBIT			(623,127$)	(568,791$)	(649,418$)	(587,259$)	(867,027$)	(644,291$)	(663,633$)	(2,144,916$)	(541,636$)	(686,467$)	(352,143$)	(509,683$)
EBITDA			(623,127$)	(568,791$)	(649,418$)	(587,259$)	(867,027$)	(644,291$)	(663,633$)	(2,144,916$)	(541,636$)	(686,467$)	(352,143$)	(509,683$)

Copy Table ✓